title: Increased serum levels of circulating intercellular adhesion molecule 1 predict the risk of graft rejection after bone marrow transplantation for thalassemia.
abstract: Beta thalassemia is a hereditary anemia curable by bone marrow transplantation (BMT). Class 3 patients have a much worse outcome with a high incidence of rejection after BMT. Adhesion molecules, including the intercellular adhesion molecule 1 are thought to play an essential role in the rejection process. To investigate whether increased levels of soluble intercellular adhesion molecule 1 (sICAM-1) may be predictive of graft rejection, the pretransplant serum concentration of sICAM-1 of 27 beta thalassemic patients who rejected the graft was compared to that of 68 beta thalassemic patients who achieved a sustained engraftment. Fifty serum samples, obtained from marrow donors, matched for age and sex, served as controls. Beta thalassemic patients had significantly higher sICAM-1 concentrations as compared to controls (P = 0.0001). Significantly increased levels of sICAM-1 were found in the patients who subsequently rejected the graft (mean (95% CI) = 490 ng/ml (440; 540)) as compared to those with sustained engraftment (400 ng/ml (384; 415)), (P = 0.004). The mean level of sICAM-1 in patients with early rejection was significantly higher than that in patients with late rejection (P = 0.04). This may indicate a transfusion-mediated role of sICAM-1: some beta thalassemic patients with high sICAM-1 levels, induced by the transfusion support, may remain immunologically active, despite the conditioning regimen, therefore such patients are likely to have an early graft rejection. Our findings indicate that sICAM-1 could be a useful indicator of immune activation in polytransfused patients with beta thalassemia who have a high risk of rejection. Determination of sICAM-1 has potential clinical implications in predicting which patients may reject after BMT.
authors.affiliation: Divisione di Ematologia e Centro Trapianto Midollo Osseo di Muraglia, Ospedale S Salvatore, Pesaro, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Centis
authors.forename: C
authors.initials: C
authors.lastname: Delfini
authors.forename: M
authors.initials: M
authors.lastname: Annibali
authors.forename: M
authors.initials: M
authors.lastname: Galimberti
authors.forename: F
authors.initials: F
authors.lastname: Agostinelli
authors.forename: G
authors.initials: G
authors.lastname: Nicolini
authors.forename: G
authors.initials: G
authors.lastname: Lucarelli
mesh_terms: D000293:Adolescent; D016026:Bone Marrow Transplantation; D002648:Child; D005260:Female; D006084:Graft Rejection / Q000097:blood*; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood*; D008297:Male; D012307:Risk Factors; D017086:beta-Thalassemia / Q000097:blood / Q000628:therapy*
chemical_list: D018799:Intercellular Adhesion Molecule-1